Estrella Immunopharma
ESLA
3 hedge funds and large institutions have $2.96M invested in Estrella Immunopharma in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 8 closing their positions.
19.25% less ownership
Funds ownership: 32.4% → 13.16% (-19%)
64% less capital invested
Capital invested by funds: $8.18M → $2.96M (-$5.22M)
67% less funds holding
Funds holding: 9 → 3 (-6)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$207K |
| 2 |
MCP
Maso Capital Partners
Hong Kong
|
+$101K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HHGC
Hunting Hill Global Capital
New York
|
-$3.14M |
| 2 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
-$1.35M |
| 3 |
CS
Clear Street
New York
|
-$322K |
| 4 |
SOA
Sea Otter Advisors
Miami,
Florida
|
-$152K |
| 5 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$151K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OCAM
1
Owl Creek Asset Management
New York
| $2.68M | – | – | – |
|
|
2
Jane Street
New York
| $192K | +$207K | +20,505 | New |
|
|
MCP
3
Maso Capital Partners
Hong Kong
| $93K | +$101K | +10,000 | New |
|
|
HHGC
4
Hunting Hill Global Capital
New York
| – | -$3.14M | -289,548 | Closed |
|
|
SIA
5
SkyView Investment Advisors
Shrewsbury,
New Jersey
| – | -$1.35M | -125,000 | Closed |
|
|
CS
6
Clear Street
New York
| – | -$322K | -29,709 | Closed |
|
|
SOA
7
Sea Otter Advisors
Miami,
Florida
| – | -$152K | -14,026 | Closed |
|
|
MC
8
Meteora Capital
Boca Raton,
Florida
| – | -$151K | -13,947 | Closed |
|
|
RCM
9
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| – | -$137K | -12,610 | Closed |
|
|
YCM
10
Yakira Capital Management
Westport,
Connecticut
| – | -$110K | -10,143 | Closed |
|
|
FIA
11
FNY Investment Advisers
New York
| – | -$54K | -5,000 | Closed |
|
ESLA Hedge Fund Activity: Q3 2023 in Review
3 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma (ESLA) for Q3 2023, worth a combined $2.96M — down 64% from $8.18M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ESLA and 2 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Jane Street, opening a new position worth an estimated $207K. The largest seller was Hunting Hill Global Capital, exiting entirely with an estimated $3.14M sold.
- 3 institutional investors held Estrella Immunopharma (ESLA) as of Q3 2023, down from 9 in Q2 2023.
- Funds reported $2.96M of Estrella Immunopharma stock for Q3 2023, down 64% quarter-over-quarter.
- 2 funds opened new Estrella Immunopharma positions in Q3 2023 and 8 closed out, a net change of -6 holders.
- The largest Estrella Immunopharma buyer in Q3 2023 was Jane Street, an estimated $207K added.
- The largest Estrella Immunopharma seller in Q3 2023 was Hunting Hill Global Capital, an estimated $3.14M sold.
Based on aggregated 13F filings for Q3 2023.